Table 1.
Pretreatment | Posttreatment | |
---|---|---|
Body weight, g | ||
Form | 27.5 ± 0.6 | 25.3 ± 0.6*** |
Saline | 28.1 ± 0.5 | 27.9 ± 0.4 |
Food consumption, g/24 h | ||
Form | 4.1 ± 0.3 | 1.3 ± 0.1*** |
Saline | 3.9 ± 0.2 | 4.2 ± 0.8 |
Fat, % | ||
Form | 5.5 ± 0.7 | 3.9 ± 0.8*** |
Saline | 7.8 ± 0.7 | 8.6 ± 0.9* |
Lean, % | ||
Form | 94.1 ± 0.7 | 95.5 ± 0.8*** |
Saline | 92.0 ± 0.7 | 91.0 ± 0.8** |
Liver weight, g | ||
Form | - | 1.34 ± 0.06 |
Saline | - | 1.38 ± 0.05 |
Intraperitoneal injections of mice with Form (20 µg/g) or saline vehicle over 24 h, measurement of food consumption, and assessments of body fat and lean mass (%) by quantitative magnetic resonance imaging were carried out as described in materials and methods. Data are presented as means ± SE; n = 7–8 mice/group; *P < 0.05 vs. Pretreatment; **P < 0.01; ***P < 0.001.